10 결과
FIELD OF THE INVENTION
The present invention relates to compositions and therapeutic combinations for treating obesity in a subject comprising the administration of sterol and/or 5.alpha.-stanol absorption inhibitor(s) or combinations with obesity control medications.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to compositions and therapeutic combinations comprising peroxisome proliferator-activated receptor (PPAR) activator(s) and certain sterol absorption inhibitor(s) for treating vascular and lipidemic conditions such as are associated with
FIELD OF THE INVENTION
The present invention relates to compositions and therapeutic combinations comprising peroxisome proliferator-activated receptor (PPAR) activator(s) and certain sterol absorption inhibitor(s) for treating vascular and lipidemic conditions such as are associated with
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to substituted azetidinone compounds useful for treating vascular and lipidemic conditions, and formulations and processes related thereto.
Atherosclerotic coronary heart disease (CHD) represents the major cause for
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to substituted azetidinone compounds useful for treating vascular and lipidemic conditions, and formulations and processes related thereto.
Atherosclerotic coronary heart disease (CHD) represents the major cause for
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to substituted azetidinone compounds useful for treating vascular and lipidemic conditions, and formulations and processes related thereto.
Atherosclerotic coronary heart disease (CHD) represents the major cause for
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to substituted azetidinone compounds useful for treating vascular and lipidemic conditions, and formulations and processes related thereto.
Atherosclerotic coronary heart disease (CHD) represents the major cause for
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to substituted azetidinone compounds useful for treating vascular and lipidemic conditions, and formulations and processes related thereto.
Atherosclerotic coronary heart disease (CHD) represents the major cause for
BACKGROUND OF THE INVENTION
Field of the Invention
The present invention relates to substituted azetidinone compounds useful for treating vascular and lipidemic conditions, and formulations and processes related thereto.
Atherosclerotic coronary heart disease (CHD) represents the major cause for
BACKGROUND OF THE INVENTION
The present invention relates to a screening method for SREBP (sterol regulatory element binding protein) pathway-specific inhibitors. The present invention also relates to therapeutic agents for hyperlipemia, arterial sclerosis, obesity or cancer containing an SREBP